Dropping by Your Local.com – The Merging of Channels of Distribution for OTC Drugs

Posted on April 29, 2013 by Laura Mahecha, Industry Manager - Healthcare

With brick-and-mortar stores and online retailers already heavily competing for the consonline_drugsumer dollar in nearly all segments, OTC drug marketers should also be poised to take advantage of expanding sales and markets through both traditional channels and e-channels. The lines between these channels are blurring as online OTC drug retailers are offering brick-and-mortar store pickup, and mass merchandisers increase their presence online.

For example, Amazon.com now offers consumers the possibility to collect their online purchases at selected Staples and 7-Eleven stores, while mass brick-and-mortar merchandiser Walmart expects to earn $9 billion in 2013 in global sales through its website (Walmart.com), making it the fourth largest online retailer.  (more…)

Filed under: Healthcare | Tagged: , , , , , | Leave a Comment »

Nutritional products create buzz with several M& A deals in the OTC market

Posted on April 2, 2013 by Laura Mahecha, Industry Manager - Healthcare

The overall O?????????????????????????????????????????????????????????????????????????????????????TC market has not shown much excitement as of late, especially with low to no growth, manufacturing plant shut downs and brand recalls.  However, in the nutritional products segment of the market, there is rapid growth and excitement and there have been several high profile acquisitions in this space recently showing that many companies are moving into this area in order to bolster their traditional OTC businesses. In late 2012, Reckitt Benckiser and Bayer dueled for Schiff with Reckitt Benckiser the victor after bidding over $1 billion for the maker of MoveFree. (more…)

Filed under: Healthcare, Uncategorized | Tagged: , , , , , | Leave a Comment »

Switches of a whole new breed

Posted on February 13, 2013 by Laura Mahecha, Industry Manager - Healthcare

Given that many of the most obvious “switchable” drugs and categories have already taken place, opportunities that remain in moving medicines from prescription to nonprescription status require extensive research and novel approaches in order to gain FDA approval and be used by consumers safely and effectively without a prescription. There are several opportunities for new product launches in this vain however, the roadmap to get to market remains unclear for novel switches with many unanswered questions. Pharmaceutical companies struggle with the risks of hefty spending on clinical and consumer research to support a switch with unsure outcomes and concerns about the timing of private-label competition if approval is granted. (more…)

Filed under: Healthcare | Tagged: , | Leave a Comment »

Healthcare Industry Shows Signs of Recovery

Posted on December 17, 2012 by Laura Mahecha, Industry Manager - Healthcare

h As 2012 comes to a close, the U.S. OTC market shows signs of modest growth and recovery. Several companies that were once small in size have grown to become medium to large players, mainly from acquisitions of groups of brands. The largest firms have become leaner and streamlined their brand portfolios. (more…)

Filed under: Healthcare | Tagged: , | Leave a Comment »

Health and Wellness 2.0

Posted on December 4, 2012 by Laura Mahecha, Industry Manager - Healthcare

Health & Wellness DevicesHealth and wellness devices are largely untapped and can be a burgeoning opportunity for healthcare, beauty, and technology manufacturers, finds Kline & Company’s new Health and Wellness Devices report. One of the trends driving the strong growth in this market is that consumers are looking to build healthier lifestyles in order to improve their quality of life and reduce medical costs. Health-conscious consumers are also slowly shifting their focus to home care using devices such as blood glucose and pressure monitors, heart rate monitors, pedometers, teeth whitening devices, etc. (more…)

Filed under: Chemicals, Consumer Products, Personal Care | Tagged: , | Leave a Comment »

U.S. OTC Market Posts Solid Growth in 2011 Driven by Rx-to-OTC Switches and Marketing

Posted on March 13, 2012 by Laura Mahecha, Industry Manager - Healthcare

Image

From 2010 to 2011, the U.S. OTC drug market posted a gain of 2.4% from $20.9 billion in 2010 to $21.4 billion in 2011 at the manufacturers’ level. The fastest growing categories include allergy relief products, which grew 16.3% in 2011 aided by the market launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) and the strong growth of private-label allergy relief products. Past Rx-to-OTC switch brands continue to perform well with Rogaine (Johnson & Johnson) and Plan B (Teva Pharmaceutical), both posting strong gains in the hair regrowth products and contraceptives markets, respectively.

(more…)

Filed under: Healthcare | Tagged: , , , , , , , , , , , , , , , , , , , , , | Leave a Comment »

New Data Shows Plenty of Room for Innovators of All Sizes in OTC Market

Posted on December 7, 2010 by Laura Mahecha, Industry Manager - Healthcare

The over-the-counter drug market is heating up as consumers turn increasingly toward self-medication in an effort to minimize out-of-pocket healthcare costs. With increasing competition from private-label products, blockbuster switches, and somewhat unconventional entries into the OTC drug business, new data reveals that while innovation doesn’t necessarily equate to superb business performance, there is plenty of room for players of all sizes and shapes in the nonprescription drugs market. More… (more…)

Filed under: Healthcare | Tagged: , , , | Leave a Comment »

Prominent OTC companies on hand at CHPA’s Market Exchange

Posted on October 25, 2010 by Laura Mahecha, Industry Manager - Healthcare

Over-the-counter (OTC) medicines and                                                                        nutritional supplements play an increasingly vital role in America’s healthcare system. Sales continue to grow in spite of the recent recession, as customers seek cost-effective treatment options. Some OTC categories have even benefited from the economic downturn. (more…)

Filed under: Healthcare | Tagged: , , | Leave a Comment »

Branded OTC Product Recalls

Posted on October 1, 2010 by Laura Mahecha, Industry Manager - Healthcare
The largest OTC company, Johnson & Johnson’s McNeil Consumer Healthcare, has been plagued by a series of product recalls recently and this has widespread repercussions to the OTC industry. The problems have ranged from moldy odors and contaminated shipping palettes, to concerns about levels of active ingredients in products, and concerns about product safety and manufacturing quality controls at the firm’s Fort Washington, PA site. The recalls have prompted Congressional hearings and have affected several major brands across multiple categories including both adult and children’s medications in the Tylenol, Motrin, Benadryl, and Zyrtec lines. (more…)

Filed under: Healthcare | Tagged: , | Leave a Comment »

OTC Industry Looks to High-Growth OTC Switches to Fuel Industry Growth

Posted on June 24, 2010 by Laura Mahecha, Industry Manager - Healthcare

Amid mounting pressure from generics and private-label products, branded drug manufactures are counting on Rx-to-OTC switches to drive growth and keep revenues flowing. Recent switches have generated $1 billion—about 10% of total industry sales for 2009—making this an attractive path for drug makers. With a number of potentially huge switches on the horizon, the next few years could see a flurry of activity that will drive post-recessionary growth through 2014. read more…

Bookmark OTC Industry Looks to High-Growth OTC Switches to Fuel Industry Growth

Filed under: Healthcare | Tagged: , , , , | Leave a Comment »

Next Page »
Follow

Get every new post delivered to your Inbox.

Join 800 other followers